APOLLOHOSP

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) - Overview

Apollo Hospitals Enterprise Ltd. is a leading integrated healthcare provider in India with a strong presence across hospitals, pharmacies, primary care, and diagnostics. The company's business segments include: Healthcare Services: The core hospital business, which accounts for the largest portion of revenue. Retail Health and Diagnostics: A segment focused on clinics and diagnostic centers. Digital Health and Pharmacy Distribution: This includes the procurement and distribution of pharmaceuticals and other products through a digital platform (e.g., Apollo 24/7). Others: Includes various other ancillary services. Key Financials and Performance (As of Q4 FY25 and Full Year FY25) Market Capitalization: Approximately ₹1,03,000 Crore. Share Price: As of August 8, 2025, the share price on the NSE is around ₹7,131.50. It's important to note that the price can fluctuate throughout the day. P/E Ratio: The trailing twelve-month (TTM) P/E ratio is approximately 70.9, which is a significant premium to its peers. Revenue (FY25): The company's consolidated revenue for the financial year ended March 31, 2025, was ₹21,794 Crore, a 14% increase year-over-year (YoY). Profit After Tax (PAT) (FY25): PAT for FY25 grew by 61% YoY to ₹1,446 Crore. Dividend Yield: The expected dividend yield is approximately 0.27%. Debt to Equity Ratio: The debt-to-equity ratio is around 0.39, indicating a moderate level of leverage. Return on Equity (ROE): The ROE is approximately 19.1%. Recent Developments and Strategic Initiatives Demerger of Digital and Pharmacy Business: The company is in the process of demerging its omnichannel pharma and digital health businesses into a new entity. This strategic move aims to unlock value by creating India's largest omnichannel pharmacy platform, with a revenue target of ₹25,000 Crore by FY27.